Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Schedule of various warrants/options issued and outstanding


Description of Warrant		Number of Warrants				Issuable Shares				Exercise Price per Share				Weighted Average Remaining Life (Years)
Series B Warrants			75,000				2,132			$	0.10				N/A	⁽¹⁾
January 2025 Warrants			449,193				449,193			$	1.31	⁽²⁾			3.76
Series A			19,564,585				901,943			$	1.31	⁽³⁾			3.49
2021 Warrants			514,290				5,149			$	332.00				5.64
2022 Repriced Warrants			88,803				891			$	450.00				1.00
2022 Warrants			59,202				599			$	910.00				1.00
			20,751,073				1,359,907

(1)	Series B Warrants do not have an expiration date.
(2)	Reflects January 2025 Warrants. In connection with the Warrant Inducement, the exercise price was reduced from $2.36 to $1.31 per share.
(3)	The Series A Warrants were part of the Warrant Inducement, and their exercise price was reduced from $5.206 to $1.31 per share.

Schedule of assumptions

Schedule of assumptions
Warrant	Stock Price	Remaining Life (Years)	Volatility	Risk-Free Rate	Dividend
Series A	$2.02	4.12	129.9%	3.78%	—
January 2025	$2.02	4.39	129.9%	3.77%	—

Schedule of common stock shares reserved for future issuance


Exercise of 2021 and 2022 Warrants			6,639
Exercise of Stock Options – 2021 Plan			214,358
Exercise of Series A Warrants			901,943
Exercise of Series B Warrants			2,132
Exercise of January 2025 Warrants			449,193
Exercise of Pre-Funded Warrants			144,498
Settlement of RSUs			55,000
Total shares of common stock reserved for future issuances			1,773,763